Atlas Trials

Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fasting Conditions

Clinical trial NCT01523093 · COMPLETED

Trial details

NCT number
NCT01523093
Sponsor
Ranbaxy Laboratories Limited
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Healthy
Start date
2006-07-01
Primary completion
2006-07-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.